| Literature DB >> 17471072 |
Tetsuhiro Niidome1, Keita Takahashi, Yasuaki Goto, Saori Goh, Naoki Tanaka, Kaeko Kamei, Masatoshi Ichida, Saburo Hara, Akinori Akaike, Takeshi Kihara, Hachiro Sugimoto.
Abstract
Mulberry leaf has been reported to possess medicinal properties, including hypoglycemic, hypotensive and diuretic effects. Little is known, however, about its medicinal properties for central nervous system disorders, including Alzheimer's disease. Accumulating evidence suggests that amyloid beta-peptide (1-42) plays an important role in the etiology of Alzheimer's disease. Here we show that mulberry leaf extract inhibits the amyloid beta-peptide (1-42) fibril formation by both the thioflavin T fluorescence assay and atomic force microscopy. Furthermore, mulberry leaf extract protected hippocampal neurons against amyloid beta-peptide (1-42)-induced cell death in a concentration-dependent manner. These results suggest that mulberry leaf extract provides a viable treatment for Alzheimer's disease through the inhibition of amyloid beta-peptide (1-42) fibril formation and attenuation of amyloid beta-peptide (1-42)-induced neurotoxicity.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17471072 DOI: 10.1097/WNR.0b013e3280dce5af
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837